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Strong association between IgA nephropathy and HLA-DR4 antigen.
Although the etiology and pathogenesis of IgA nephropathy is not fully
understood, it has been classified as an immune-complex induced
glomerulonephritis caused by an immunological mechanism. Forty-two
patients with primary IgA nephropathy underwent tissue typing for
HLA-A, B, and DR antigens by the standard method using a microlym-
phocytotoxicity test. There was no significant correlation between
HLA-A and B antigens and this disease. However, the frequency of
HLA-DR4 was 57.1% in the patients with normal renal function, 85.7%
in those with decreased renal function, 100% in dialysis patients, and
39.2% in the control group. It is statistically significant in the patients
with renal dysfunction (corrected P < 0.05). Our results suggest that the
HLA system may play an important role in the occurrence and
exacerbation of IgA nephropathy in the Japanese population.
Association étroite entre Ia néphropathie a IgA et l'antigène HLA-DR4.
Bien que l'étiologie et la pathogenie de Ia nephropathie a IgA ne soient
pas completement comprises, elle a etC classée comme une glomCrulo-
nCphrite induite par des complexes immuns, due a un mCcanisme
immunologique. Quarante deux malades avec une nCphropathie a IgA
primitive ont eu un typage tissulaire pour les antigènes HLA-A, B, et
DR en employant Ia mCthode standard utilisant le test de microlympho-
cytotoxicité. Ii n'y avait pas de correlation significative entre les
antigènes HLA-A et B et cette maladie. Cependant Ia frCquence de
HLA-DR4 Ctait de 57,1% chez les malades avec une fonction rénale
normale, 85,7% chez ceux ayant une fonction rCnale diminuCe, 100%
chez les malades dialyses, et 39,2% dans le groupe contrôle. Elle était
statistiquement significative chez les malades ayant une dysfonction
rCnale (P corrigC < 0,05). Nos résultats suggèrent que Ic système HLA
pourraitjouer un role important dans Ia survenue et l'exacerbation de La
néphropathie a IgA dans Ia population japonaise.
IgA nephropathy, first reported by Berger [1], is character-
ized pathologically by mesangial granular deposits of IgA, with
or without other immunoglobulins, and complement in patients
with no evidence of systemic diseases. Patients with this
disorder usually are found to have chance proteinuria and/or
hematuria. The clinical course of IgA nephropathy is consid-
ered generally to be benign, but in adults this is not always the
case, sometimes requiring dialysis and transplantation. The
disease is regarded as an immune-complex-induced glomerulo-
nephritis caused by immunopathogenic agents [21 because of
the following reasons: mesangial deposition of IgA, IgG, and C3
[1]; increased serum IgA levels [31; the presence of IgA
containing immune complex [4]; and a high recurrence rate of
IgA nephropathy in renal transplant recipients [5].
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The HLA system controls transplantation antigens, some
components of the complement system, and most likely a
variety of immune responses. A recent study of HLA suggests
that the HLA-DR locus may correspond to Ia antigens in mice
and they appear to influence various aspects of humoral and
cellular immune functions, including immune responsiveness.
Since the association between the major histocompatibility
complex and the susceptibility to diseases in animal models has
been reported, numerous reports have described a correlation
of HLA to some immunopathogenic diseases [6].
Because of the immunological background of this disease and
its high incidence in Japan, we have investigated the association
between HLA and IgA nephropathy in this paper.
Methods
Forty-two patients were diagnosed as having primary IgA
nephropathy by clinical features and positive findings from
renal biopsy specimens, including examination by light micros-
copy and immunofluorescence antibody techniques. It was
differentiated from Henoch-Schönlein purpura nephritis be-
cause none of the patients had purpura, cutaneous petechiae,
abdominal pain, or arthralgia. Also, hepatic cirrhosis and other
systemic diseases possibly producing similar changes in renal
biopsy specimens were excluded by appropriate laboratory
data.
Patients in this study were divided into two groups according
to their level of renal function as determined by the serum
creatinine concentration and the endogenous creatinine clear-
ance. The patient was said to have decreased renal function
when the serum creatinine concentration was over 2.0 mg/mI
and/or the endogenous creatinine clearance was less than 60 ml/
mm.
Group 1. Of the patients with normal renal function who had
IgA nephropathy, 16 were male and 12 female, aged 13 to 50
years (mean age, 29.3 years; age of onset was 7 to 48 years,
mean age, 23.6 years). Eleven patients had hematuria, seven
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Table 1. Clinical data at time of diagnostic evaluation in group I
a Abbreviations in this column are: M, minimal lesion; F, focal proliferative glomcrulonephritis; D, diffuse proliferati'e glomerulonephritis.
Table 2. Clinical data at time of diagnostic evaluation in group 2
Patient no. Age Sex Onset age Age at biopsy 1-lematuria Proteinuria Hypertension Serum Cr Biopsy diagnosish
1 22 M 17 17 + + 1.2 F
2a 35 M 32 32 + + + 1.7 D
3a 50 M 26 39 + + + 1.2 D
4 31 F 23 24 + + 0.8 D
5a 45 M 39 39 + + 1.4 D
6a 23 M 19 21 + + 1.3 D
7 56 F 51 51 + + + 1.3 F
8 49 F 26 43 + 1.2 D
9 30 F 16 25 + + 1.0 D
10 32 M 28 27 + + + 3.3 F
11 43 M 28 39 + + + 1.1 D
12 40 M 35 38 + + 2.0 D
13 56 M 55 55 + 1.4 D
14 47 M 22 43 + + 1.5 M
a Patient was on hemodialysis at time of study.
b Abbreviations for this column are: M, minimal lesion; F, focal proliferative glomerulonephritis; D, diffuse proliferative glomerulonephritis.
proteinuria, and ten exhibited both hematuria and proteinuria at
the time of diagnostic evaluation. Only two patients were
hypertensive. According to the classification of light micro-
scopic findings, eight patients had minimal lesions, ten had
focal proliferative glomerulonephritis, and ten had a diffuse
proliferative glomerulonephritis. The follow-up period was 5.79
4.07 years (Table 1).
Group 2. Of the patients with decreased renal function, ten
were male and four were female, aged 22 to 56 years (mean age,
39.9 years; age of onset was 17 to 55 years, mean age, 29.8
years). Eleven patients had hematuria and proteinuria, and
three had proteinuria alone at the time of diagnosis. Six patients
had hypertension. One had minimal lesions, three had focal
proliferative glomerulonephritis, and ten had a diffuse prolifera-
tive glomerulonephritis on light microscopic examination. The
follow-up period was 10.14 8.14 years. In this group, there
were six dialysis patients, five males and one female. It was 1 to
19 years from onset to dialysis treatment (Table 2).
HLA phenotyping was done with the standard microlympho-
cytotoxicity technique using Terasaki's microplate. The details
of HLA-DR typing have been described elsewhere [7]. Tissue-
typing antisera for the patients with IgA nephropathy and the
Patient no. Age Sex Onset age Age at biopsy Hematuria Proteinuria Hypertension Serum Cr Biopsy diagnosisa
1 38 M 36 36 + 1.7 D
2 35 M 23 2X + 0.8 D
3 28 M 19 23 + 1.1 F
4 25 M 18 21 + + 0.8 D
5 17 M 13 14 + 0.8 F
6 15 F 13 13 + 0.8 D
7 13 F 11 11 + + 0.9 F
8 25 F 20 21 + 1.1 M
9 39 F 31 34 + 0.9 D
10 17 M 14 14 + 0.7 M
II 41 M 37 38 + f 1.4 F
12 20 M 17 18 + + 1.1 M
13 16 M 12 13 + 1.3 M
14 19 M 11 13 + 0.7 F
15 37 M 28 35 + 1.0 F
16 35 F 30 30 + 1.3 F
17 25 M 18 21 + 1.0 M
18 40 F 34 34 + + 0.7 F
19 31 F 26 26 + + 0.9 F
20 34 F 30 30 + 0.8 F
21 29 F 25 27 + 0.9 D
22 26 F 7 12 + + 0.7 D
23 16 F 14 14 + 0.8 D
24 39 M 29 38 + + + 1.0 D
25 45 F 44 44 + + 1.1 M
26 32 M 31 31 + 1.2 M
27 50 M 48 49 + + 1.8 D
28 34 M 21 29 + + 1.3 M
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Table 3. HLA-A, B and DR phenotype frequencies and statistical analysis in IgA nephropathy
control subjects were 8 HLA-A, 19 HLA-B, and 10 HLA-DR
antigens. The ten HLA-DR antigens were DRI-5, DRw6, DR7,
DRw8, SRw9, and NJ1, which were obtained locally and well
characterized by the 7th Japanese Histocompatibility Work-
shop. The NJI antigen was agreed to be a new DR antigen in the
Workshop. Therefore the phenotypic frequency of DR antigens
was somewhat different from that used in the previous study
[8].
The control subjects numbered 140 for HLA-A and B anti-
gens and 158 for HLA-DR antigens. Statistical significance was
determined by Fisher's exact test, and the values were correct-
ed for the number of different antigens tested. The relative risk
of this disease was calculated according to the method of
Svejgaard and Ryder [9].
Results
The frequency of HLA-A, B, and DR antigens in the patients
with primary IgA nephropathy and the control populations is
shown in Table 3.
In HLA-A and B locus typing, the frequencies of A3, Bw44,
Bw22, Bw54, and Bw35 were higher in group 1 than in the
controls. Also, the frequencies of A2, A26, All, B15, Bw44,
Bw22, Bw35, and Bw61 were higher in group 2 than in the
controls. However, after correction the frequency of Bw44,
Bw54, and Bw35 in group 1 was not significantly higher than
that of controls.
In HLA-DR locus typing, the DR4 antigen was detected in 16
patients in group 1(57.1%) and 12 patients in group 2 (85.7%).
All six patients under dialysis treatment had the DR4 antigen.
On the other hand, DR4 was detected in 62 of 158 (39.2%) of the
control subjects. The frequency of DR4 increased more promi-
nently as renal function deteriorated. The corrected P was
3.5779 in group 1, 0.0407 in group 2, and 0.1628 in the dialysis
patients. The relative risk was more than 2.06 (Table 4). In our
previous study of HLA in primary IgA nephropathy, we
demonstrated the association between IgA nephropathy and
HLA-DR4 antigen (66.7% in the patients vs. 29.7% in the
controls, P = 0.0016, relative risk = 4.74) [8]. But, the previous
HLA antigen
Group 1Controls
% % Pvalue %
Group 2
P value
Al 2.9
A2 35.0 42.9 0.5191 57.1 0.1453
A3 0.7 3.6 0.3064
Aw24 64.3 67.9 0.8297 64.3 1.0
A26 14.3 10.7 0.7694 28.6 0.2360
All 10.0 10.7 1.0 28.6 0.0621
Aw3l 14.3 10.7 0.7694
Aw33 10.0 10.7 1.0 7.1 1.0
B5 35.0 39.3 0.6710 21.4 0.3853
Bw51 12.9 10.7 1.0 14.3 1.0
Bw52 22.1 25.0 0.8052 7.1 0.3028
B7 12.9 10.7 1.0
B8 0.7
Bw44 9.3 25.0 0.0482a 21.4 0.1638
Bl3 1.4 3.6 0.4234
B15 21.4 14.3 0.4533 35.7 0.3119
Bw16 5.7 3.6 1.0 7.1 0.5861
Bl7 3.6 3.6 1.0
B18 0.7
B21 0.7
Bw22 2.9 10.7 0.0915 7.1 0.3832
B27 2.1
Bw54 12.1 25.0 0.0476a
Bw35 12.9 28.6 0.0464a 28.6 0.1181
Bw60 13.6 14.3 1.0
Bw6l 18.6 17.9 1.0 35.7 0.1589
Bw48 1.4
DRI 12.0 17.9 0.3703
DR2 30.4 21.4 0.3769 21.4 0.7607
DR3 1.3
DR4 39.2 57.1 0.0967 85.7 0.OOllb
DR5 5.7 10.0 0.3948
DRw6 1.9
DR7 0.6
DRw8 25.9 14.3 0.2351 7.1 0.1922
SRw9 26.6 21.4 0.6462 21.4 1.0
DRNJ1 14.6 21.4 0.3962 24.1 0.4475
a P < 0.05.
b P < 0.005.
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Table 4. Statistical analysis of HLA-DR4 in the patients with IgA
nephropathy
Normal renal Decreased renal
function function Hemodialysis
Frequency 57.1% 85.7% 100%
P value 0.0967 0.0011 0.0044
Corrected P 3.5779 0.0407 0.1628
Relative risk 2.06 9.29
materials included different stages of the renal lesion in lgA
nephropathy. We tried to investigate the correlation between
HLA-DR4 antigen and the prognosis of IgA nephropathy in this
study. In conclusion, only the relation between group 2 with
decreased renal function and DR4 had statistical significance.
Although all six dialysis patients had DR4 antigen, it was not
statistically significant after correction because of the small
number of patients.
One instance of familial IgA nephropathy was found by
chance in group 2. A 20-year-old man was diagnosed as having
IgA nephropathy with chance proteinuria and hematuria in 1976
and underwent hemodialysis after 4 years. His HLA type was
A26, All, Bw61, B 15, DR4, DRw9. His 45-year-old mother was
examined because she was the potential donor for a living
related kidney transplantation. She was found to have mild
proteinuria and microscopic hematuria on routine testing. Her
renal biopsy specimen revealed IgA nephropathy. Her HLA
type was A2, A26, Bw6l, DR4, DRw9. They shared the
haplotype-A26, Bw61, DR4 (Fig. 1).
Discussion
In the advance of modern immunology, the pathogenesis of
human nephritis has been clarified by sophisticated immunolog-
ical techniques for diagnosis and experimental studies of ne-
phritis in animal models. One disorder in which nephrologists
are concerned is IgA nephropathy.
Berger reported a new type of nephritis which is character-
ized pathologically by diffuse intercapillary deposits containing
IgA, IgG, and C3, with superimposed focal glomerular changes,
and clinically by the presence of mild proteinuria, microscopic
or gross hematuria, and which progressed very slowly [1]. The
incidence of this disease was reported to be 18 to 20% in France
[1, 10], 4.3 to 16% in the United States [11, 12] and a low
occurrence in England [13]. However, it is very common in
Japan; its frequency is 42 to 64% in the patients with chance
proteinuria and/or hematuria [14, 15] and 21 to 34% in renal
biopsy specimens [16, 17]. Despite the high incidence of this
disease the clinical course is usually mild with 6 to 15% of the
patients suffering from renal failure and only a few percent
receiving dialysis treatment [17].
Although the etiology of IgA nephropathy is not well defined,
it is now understood that it may be caused by some immunologi-
cal mechanism, largely because of the immunological findings
in renal biopsy specimens, increased serum igA levels, the
presence of circulating igA immune complex, and high recur-
rence of this disorder in renal allograti. For these reasons, IgA
nephropathy has been classified by some as an immune-com-
plex-induced glomerulonephritis [2].
Since it has become apparent that the HLA system, the major
histocompatibility complex in humans, corresponds to the H-2
system in mice, numerous reports have described the associa-
tion between HLA and susceptibility to disease. This was
stimulated initially by discoveries of linkage between the major
histocompatibility complex and some diseases in mice. in an
experimental model of nephritis, Hyman et al demonstrated
that autoimmune tubulointerstitial nephritis to the tubular base-
ment membrane in guinea pigs can be induced by the injection
of heterogenous renal cortex in strain XIII but not in strain II
[18]. Breeding experiments have shown that this susceptibility
is linked to the major histocompatibility complex [19].
Noel et al described that HLA-Bw35 was present in 48% of
patients with glomerulonephritis having IgA mesangial deposits
as compared to 18% in controls, and all of the patients reached
the terminal stage of uremia [20]. Berthoux et a! reported the
high incidence of Bw35 (36% in the patients versus 13% in the
controls) and a significant increase of mean IgA levels in this
group [21]. They also suggested that Bw35 might be a marker
for poor prognosis in this disease because of 50% of patients
with Bw35 progressed to a stage of chronic renal failure.
Sabatier et al [221 and Katz, Karanicolas, and Falk [23] reported
familial IgA nephropathy among siblings with HLA-Bw35. On
the other hand, Brettle, Peters, and Batchelor [24] reported the
association between HLA-Cwl and this disease (29% in the
patients vs. 4% in the controls), although it is relatively rare in
England, and Richman, Mahoney, and Fuller [25] reported a
high incidence of HLA-B12 (59% in the patients vs. 20% in the
controls) in the United States. It is interesting that the singular
high frequency of HLA antigens in IgA nephropathy varies
from country to country; this could suggest that it may be a
heterogenous disease. However, we could not demonstrate any
statistical significance of the frequency of HLA-A and B
antigens of this disease although Bw44, Bw54, and Bw35 were
frequent in those with normal renal function.
In a recent study of major histocompatibility complex, a great
deal of information has been obtained about the function of
HLA in the regulation of immune response. The primary
immunoregulatory function of the HLA-A, B and C gene
products appears to determine the number and specificity of
cytotoxic killer T-cells. HLA-D-region gene products appear to
influence the efficiency of interaction among T-cells, B-cells,
and macrophages [26]. HLA-DR, which is typed with iso-
antisera specific for HLA-D locus genotype, is recognized to
correlate with I region in the H-2 system of mice. From the view
point of these immunological evidences, there have been some
s.s.
A26 8w52 DR2
All B15 DRw9
53 45
K .S.
. A2 Bw61 DRw9
A26 Bw61 DR4
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Q A!! B15 lJRw9
A2 Bw61 DRw9
20 18
M .S.
All 815 DRw9
_____________A26 Bw61 0R4
Fig. 1.Pedigree andHLA genotypes offamily S. Symbols: 10, normal
male and female; U •, affected male and female.
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reports of the correlation between some immunological dis-
eases and HLA-DR antigens.
Brettle, Peters, and Batchelor [24] could not find any associa-
tion between HLA-DR antigens and IgA nephropathy but,
Fauchet et al [27] recently reported a significant association
with DR4 (48.9% in the patients vs. 19.5% in the controls) and
two antigen's association involving DR4: Bw35 with DR4 and
B12-DR4 with A2-B12-DR4. The latter's result in France corre-
lates with our preliminary data [8]. In addition, we demonstrat-
ed in this study that DR4 frequency was high in patients with
severe renal dysfunction and 100% in dialysis patients.
Hiki et al [28] suggested that there might be a linkage between
the onset of IgA nephropathy and HLA-Bw35 and that DR4
could be a marker for IgA nephropathy with a favorable course
in the Japanese population. The observed frequency of Bw35
was almost the same as ours (26% vs. 28.6%), but, we could not
demonstrate statistical significance of Bw35. Then, they
showed a significant frequency of DR4 in the patients who kept
normal renal function over 3 years and suggested that it can be a
marker for favorable course of this disease. The discrepancy
between our results and theirs may depend on the follow-up
period. The follow-up period in our study was over 5 years in
ten out of 14 patients with renal dysfunction; the mean time was
10.14 8.14 years. In our previous study, about 60% out of 150
patients under hemodialysis had DR4 antigen, and many of
them might have suffered from IgA nephropathy, which was
impossible to be diagnosed at that time.
On the other hand, Komori et al [29] reported a high
frequency of HLA-DEn in this disease, which is strongly
related to HLA-DRw6 in the Japanese. It is suggested that there
may be a heterogenesity in IgA nephropathy in the Japanese
population.
There have been some reports of a familial occurrence of IgA
nephropathy. Sabatier et al [22] and Katz, Karanicolas, and
Falk [23] reported on familial IgA nephropathy in siblings with
HLA-Bw35. Montoliu et al [301 reported on familial IgA
nephropathy in two siblings who shared the DR4 antigen but
who were HLA-A, B, and C unrelated. We also found familial
IgA nephropathy in a mother and son, who shared the haplo-
type, A26-Bw61-DR4. Tolkoff-Rubin et al [311 demonstrated a
case of endstage IgA nephropathy in a patient who received a
renal graft from his asymptomatic FILA identical brother,
which was found to have clinically occult IgA nephropathy,
diagnosed from a 1-hr biopsy specimen. These results may
suggest strongly that a genetically induced abnormality of
immune response can cause some cases of IgA nephropathy
and that close blood relatives of the patient should be checked
for the possible existence of renal diseases, including the HLA
type.
We conclude that the HLA system, especially HLA-DR4,
may play an important role in the occurrence and exacerbation
of primary IgA nephropathy. However, the causative antigen
has not yet been detected and the correlation between the HLA
system and abnormalities in subsets of the immune response
system has yet to be clarified.
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